NFKB1 and cancer: While TGFβ drives a myCAF phenotype, inflammatory CAF differentiation can be mediated via JAK/STAT—and NfKB signalling and a subset of iCAFs in cancer is defined by interferon signalling and termed interferon‐licenced/interferon‐regulated fibroblasts [5, 6, 15, 19].